TrialBMC cancer2026

Adjuvant pressurized intraperitoneal aerosol chemotherapy (PIPAC) in suboptimally cytoreduced advanced ovarian cancer: a randomized phase II trial (PIPAC-OVA).

Alexey S Dzasokhov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.